ABL1 and cancer: In summary, the present study establishes the minimal region of apoptin interaction domain with BCR-ABL1 and further shows the anti-cancer effect of the cell-permeable version of apoptin decapeptide (aa 81-90) on the BCR-ABL1 expressing mouse and human cell lines.